Total score ranges from 0-60; increases indicate improvement. 20-item questionnaire with total score ranging from 0-80; decreases indicate improvement. Conclusions: At Year 3, high virologic suppression rates and few discontinuations for virologic reasons were observed with DTG+3TC; no resistance was reported. Treatment was well tolerated, with minimal lipid and liver parameter changes. Pretreated PLHIV reported statistically significant improvements in treatment satisfaction. General conditions 1. I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after the submission deadline and I am aware that it will be published exactly as submitted.: Yes 2. I confirm that the submission of the abstract constitutes my consent to publication (e.g. conference website, programmes, other promotions, etc.). : Yes 3. I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.: Yes 4. I agree that all data provided may be used (saved, stored, processed, transmitted and deleted) in compliance with the privacy policy to provide the services described.: Yes b c 143
RkJQdWJsaXNoZXIy Mzc2ODc=